Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
PubMed Central PMCID: PMC6762047
InChi: InChI=1S/C29H40N4O7
Fosaprepitant is a weak inhibitor of CYP3A4
5S)-5-(hydroxymethyl)-2
Telbivudine Catalog No.:M9354-10 PubMed Central PMCID: PMC6762047Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (Europe) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance. Telbivudine is a synthetic thymidine nucleoside analogue; it is the L isomer of thymidine. Product information CAS
US$ 72.00
US$ 2079.00
US$ 20.00
US$ 30.00
US$ 25.00
US$ 40.00
US$ 12051.00
US$ 40.00
US$ 40.00
US$ 1391.50